SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-033471
Filing Date
2024-04-16
Accepted
2024-04-16 16:38:19
Documents
13
Period of Report
2024-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea020390801-8k_adialpharm.htm   iXBRL 8-K 22298
  Complete submission text file 0001213900-24-033471.txt   197672

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adil-20240410.xsd EX-101.SCH 3060
3 XBRL LABEL FILE adil-20240410_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE adil-20240410_pre.xml EX-101.PRE 22389
16 EXTRACTED XBRL INSTANCE DOCUMENT ea020390801-8k_adialpharm_htm.xml XML 3773
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 24848298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)